We strongly advise you to harness Intec Pharma fundamental analysis to see if markets are presently mispricing the organization. In other words this interface allows you to validate available fundamentals of Intec Pharma as well as the relationship between them. . We found seventeen available reported financial drivers for Intec Pharma which can be compared to its competitors. Use Intec Pharma Ltd Current Ratio, Cash Flow from Operations, Number of Employees, as well as the relationship between Book Value Per Share and Earnings Per Share to make sure your decision on pricing Intec Pharma is adequate. Use Intec Pharma to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Intec Pharma to be traded at 1569.75 in 30 days
Intec Pharma Company Summary
Intec Pharma competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, and Israel Chemicals. Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel. Intec Pharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 70 people.
Intec Pharma Ltd is rated below average in number of employees category among related companies. It is considered to be number one stock in beta category among related companies totaling about 0.01 of Beta per Number of Employees. The ratio of Number of Employees to Beta for Intec Pharma Ltd is roughly 67.96
Intec Pharma Market Fundamentals
Intec Pharma Financial Distress Probability
Chance of Financial Distress
Intec Pharma Ltd has less than 41 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info